To further investigate the role of phosphorylated ERK1/2 and Nanog expression in HNSCC patients, we examined the expression of phosphorylated ERK1/2, CD44, Nanog, and Snail in the tumor tissues of five patients (Fig. 6e). This evidence concerns the gene NANOG and head and neck squamous cell carcinoma.